{"id":"https://openalex.org/W2367775454","doi":null,"title":"Antidepressant Mechanism and Pharmacodynamic Characteristics of Venlafaxine and Fluxetine Based on Metabolomics","display_name":"Antidepressant Mechanism and Pharmacodynamic Characteristics of Venlafaxine and Fluxetine Based on Metabolomics","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2367775454","mag":"2367775454"},"language":"en","primary_location":{"id":"mag:2367775454","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYX201201010.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764966987","display_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","issn_l":"1016-1015","issn":["1016-1015"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323237738","host_organization_name":"Pharmaceutical Society of the Republic of China","host_organization_lineage":["https://openalex.org/P4323237738"],"host_organization_lineage_names":["Pharmaceutical Society of the Republic of China"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030150062","display_name":"Xue Shui-yua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Xue Shui-yua","raw_affiliation_strings":["b,ZHENG Xing-yua,b,DOU Chun-yana,b,LI Zhen-yua,QIN Xue-meia,b"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b,ZHENG Xing-yua,b,DOU Chun-yana,b,LI Zhen-yua,QIN Xue-meia,b","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5030150062"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30638529,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10836","display_name":"Metabolomics and Mass Spectrometry Studies","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":1.0},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-mechanism-of-action","display_name":"antidepressant mechanism","score":0.8019999861717224},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.8339999914169312},{"id":"https://openalex.org/keywords/chronic-unpredictable-mild-stress","display_name":"chronic unpredictable mild stress","score":0.9369999766349792},{"id":"https://openalex.org/keywords/urine-metabolomics","display_name":"urine metabolomics","score":0.6899999976158142},{"id":"https://openalex.org/keywords/depression-biomarkers","display_name":"depression biomarkers","score":0.8080000281333923},{"id":"https://openalex.org/keywords/drug-efficacy-evaluation","display_name":"drug efficacy evaluation","score":0.6539999842643738},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.9616643190383911},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.8409994840621948},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.8343010544776917},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6306169629096985},{"id":"https://openalex.org/C2909532165","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine Hydrochloride","level":5,"score":0.5887778401374817},{"id":"https://openalex.org/C21565614","wikidata":"https://www.wikidata.org/wiki/Q12149006","display_name":"Metabolomics","level":2,"score":0.5405764579772949},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5344426035881042},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4903581142425537},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45093002915382385},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.41507506370544434},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32144981622695923},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2293895184993744},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1864989995956421},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.16193845868110657},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.11638116836547852},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.06405976414680481},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2367775454","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYX201201010.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764966987","display_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","issn_l":"1016-1015","issn":["1016-1015"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4323237738","host_organization_name":"Pharmaceutical Society of the Republic of China","host_organization_lineage":["https://openalex.org/P4323237738"],"host_organization_lineage_names":["Pharmaceutical Society of the Republic of China"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Zh\u014dnghu\u00e1 y\u00e0oxu\u00e9 z\u00e1zh\u00ec","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2111580666","https://openalex.org/W3116444726","https://openalex.org/W2168301899","https://openalex.org/W2286137651","https://openalex.org/W2981023085","https://openalex.org/W7140312088","https://openalex.org/W2945264725","https://openalex.org/W2151868810","https://openalex.org/W4382753222","https://openalex.org/W2742730966"],"abstract_inverted_index":{"OBJECTIVE":[0],"To":[1],"evaluate":[2],"and":[3,8,12,42,97,129],"compare":[4,130],"the":[5,24,57,65,79,92,125,131,134,142],"antidepressant":[6,69,83,111],"effects":[7],"mechanisms":[9,132],"of":[10,35,51,56,127,133,144],"venlafaxine":[11,74,113],"fluoxetine":[13],"by":[14,105],"metabolomic":[15],"approach.METHODS":[16],"Two":[17],"positive":[18],"drugs":[19,108],"were":[20,37,40,61,89,103],"employed":[21],"to":[22,44,47,78,123],"intervene":[23],"chronic":[25],"unpredictable":[26],"mild":[27],"stress(CUMS)":[28],"induced":[29],"rat":[30],"depression":[31],"model.The":[32],"behavioral":[33,54],"changes":[34],"rats":[36],"observed;meanwhile,urine":[38],"samples":[39],"collected":[41],"subjected":[43],"GC-MS":[45],"analysis":[46,71],"find":[48],"potential":[49,87],"biomarkers":[50,88,128],"depression.RESULTS":[52],"The":[53],"data":[55],"drug":[58,145],"treatment":[59],"groups":[60],"significantly":[62],"different(P0.05)":[63],"with":[64],"model":[66,98],"group,showing":[67],"obvious":[68],"effect.Metabolomic":[70,116],"showed":[72],"that":[73],"group":[75],"located":[76],"closer":[77],"healthy":[80],"controls,showing":[81],"better":[82,115],"efficacy":[84],"than":[85],"fluoxetine.Fifteen":[86],"identified":[90],"from":[91],"loading":[93],"plot":[94],"between":[95],"control":[96],"group,and":[99],"more":[100],"perturbed":[101],"metabolites":[102],"reversed":[104],"venlafaxine.CONCLUSION":[106],"Both":[107],"have":[109],"significant":[110],"efficacy,and":[112],"shows":[114],"approach":[117],"was":[118],"applied":[119],"in":[120],"this":[121],"study":[122],"analyze":[124],"regulation":[126],"two":[135],"drugs.These":[136],"results":[137],"provide":[138],"new":[139],"methods":[140],"for":[141],"evaluation":[143],"efficacy.":[146]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}